BE Semiconductor Industries NV (OTCMKTS:BESIY) has received an average consensus rating of “Hold” from analysts covering the company, according to data from MarketBeat. The...
Financial analysts have established a target price of $79.05 for BridgeBio Pharma, Inc. (NASDAQ: BBIO), indicating a generally positive outlook for the biopharmaceutical company....